IRLAB Therapeutics
Pre-clinicalISP – The proprietary technology platform IRLAB’s unique and resource efficient research method, the Integrative Screening Process (ISP), generates the company’s drug pipeline. This proprietary platform is built on a systems pharmacology discovery approach with an extensive, world unique, standardized database on CNS compounds and classes collected over 25 years.
About
ISP – The proprietary technology platform IRLAB’s unique and resource efficient research method, the Integrative Screening Process (ISP), generates the company’s drug pipeline. This proprietary platform is built on a systems pharmacology discovery approach with an extensive, world unique, standardized database on CNS compounds and classes collected over 25 years.
Funding History
3Total raised: $60M
Company Info
Contact
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile